Скачать или смотреть Ozempic patient blinded by NAION sues Novo Nordisk

In today’s headlines:

A man who went blind after taking Ozempic is suing NovoNordisk -the first lawsuit to come out of the emerging link between GLP-1s and NAION.

MSD is the first big pharma to put a figure on the financial hit from Trump's tariff drive.

Merck has revealed its offer price for US biotech SpringWorks as talks move to the later stages.

Hong Kong's Akeso saw big progress with its cancer immunotherapy pipeline this week.

Can a short-acting #Botox successor help shore up AbbVie's neurotoxin market share?

Find out which biotechs have been raising private financing in the last few days.

#botox #biotech #biotechnews #abbvie #cancerimmunotherapy #cancertreatment #ozempic #novonordisk #lawsuit #pharmanews #lifescience #diabetes #merck #msd #tariffs #tariffnews #glp1medication #naion #akeso